ghk cu dosage subq dosing chart for skin ghk-cu recommendations human use ghk-cu peptide injection ghk-cu subcutaneous injection dosage recommended

Reduced joint pain and improved mobility

An earlier landmark study by Staresinic et al

Preclinical studies suggest it can protect nerve cells (neuroprotective effects)

And if you feel that the initial consultation process is lacking the kind of substance that you typically associate with consultations as a new patient, we'd suggest you consider that a sign that you should seek additional medical advice elsewhere before proceeding

The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list